The IBD Disability Index should become a Major Secondary Endpoint in Clinical Practice and in Clinical Trials.

Date publication

décembre 2016

Journal

Journal of Crohn's & colitis

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Peyrin-Biroulet L, Gower-Rousseau C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27664272

Mots clés

Adult, Clinical Trials as Topic, methods, Colitis, Ulcerative, diagnosis, Crohn Disease, diagnosis, Disability Evaluation, Humans, Inflammatory Bowel Diseases, diagnosis, Quality of Life, Surveys and Questionnaires

Référence

J Crohns Colitis. 2016 Dec;10(12):1375-1377